__NUXT_JSONP__("/drugs/Guretolimod", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1488364-57-3",chebiId:b,chemicalFormula:b,definition:"A synthetic, small molecule, toll-like receptor (TLR) 7 agonist, with potential immunostimulatory and antineoplastic activities. Upon intravenous administration, guretolimod activates TLR7, resulting in type I interferon secretion and activation of  cytotoxic T-lymphocyte (CTL)-mediated anti-tumor immune responses. TLR7 is a member of the TLR family, which plays a fundamental role in pathogen recognition and activation of innate immunity.",fdaUniiCode:"2UG29YVL56",identifier:"C153314",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C177176"],synonyms:["(((4-((2-Amino-4-(((3s)-1-hydroxyhexan-3-yl)amino)-6-methylpyrimidin-5-yl)methyl)-3- methoxyphenyl)methyl)(2,2,2-trifluoroethyl)amino)acetic Acid","DSP 0509","DSP-0509","DSP0509","GURETOLIMOD",a,"TLR7 Agonist DSP-0509","Toll-like Receptor 7 Agonist DSP-0509"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FGuretolimod",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Guretolimod","","2021-10-30T13:34:02.613Z")));